STOCK TITAN

PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a leader in precision oncology, announced that David H. Mack, Ph.D., will participate in a "Fireside Chat" at the Evercore ISI 4th Annual HealthCONx Conference from November 30 to December 2, 2021. The chat is scheduled for December 2, 2021, at 11:20 am ET. PMV Pharma specializes in developing small molecule therapies targeting p53 mutations, which are prevalent in about half of all cancers. This event will also include one-on-one investor meetings.

Positive
  • None.
Negative
  • None.

CRANBURY, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will represent PMV Pharma in a “Fireside Chat” at the Evercore ISI 4th Annual HealthCONx Conference taking place November 30 – December 2, 2021. The company will also participate in one-on-one investor meetings at the conference.

Details on the presentation can be found below.

Evercore ISI 4th Annual HealthCONx Conference
Date:Thursday, December 2, 2021
Time:
11:20 am ET
Format:Fireside Chat

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit www.pmvpharma.com.

Contact

For Investors:

Winston Kung
Chief Financial Officer
investors@pmvpharma.com

 


FAQ

When will PMV Pharma participate in the Evercore ISI HealthCONx Conference?

PMV Pharma will participate in the Evercore ISI 4th Annual HealthCONx Conference from November 30 to December 2, 2021.

What time is the Fireside Chat for PMV Pharmaceuticals at the conference?

The Fireside Chat for PMV Pharmaceuticals is scheduled for December 2, 2021, at 11:20 am ET.

Who will represent PMV Pharma in the Fireside Chat?

David H. Mack, Ph.D., President & CEO, will represent PMV Pharma in the Fireside Chat.

What is the focus of PMV Pharmaceuticals' research?

PMV Pharmaceuticals focuses on developing small molecule therapies targeting p53 mutations, common in many cancers.

PMV Pharmaceuticals, Inc

NASDAQ:PMVP

PMVP Rankings

PMVP Latest News

PMVP Stock Data

76.56M
44.08M
2.3%
80.88%
1.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PRINCETON